Patent Assignment
Reel/Frame 069675/0930
Assignment of Assignor's Interest
Recorded: 2024-12-24
Pages: 5
Assignor
SHAH, PARAG
Executed: 2024-12-18
Assignee
BELLEROPHON THERAPEUTICS, INC.
184 LIBERTY CENTER ROAD, SUITE 302, WARREN, NEW JERSEY, 07059
Covered Property
(1)
USE OF INHALED NITRIC OXIDE (iNO) FOR TREATMENT OF INFECTION, INCLUDING INFECTION WITH SARS-CoV2 AND TREATMENT OF COVID-19
Application:
17/917,209 →
Publication:
US 2023/0158064
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 10, 2024
From: BELLEROPHON THERAPEUTICS, INC. / BELLEROPHON PULSE TECHNOLOGIES LLC
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 067678/0618 →
Security Interest
Aug 1, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 072331/0001 →
Security Interest
Oct 28, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 073375/0395 →